BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28986606)

  • 1. Effect of breviscapine on CYP3A metabolic activity in healthy volunteers.
    Zhou X; Gao YY; Hu JY; Dong Y; Zhang HZ; Lai Y
    Eur J Clin Pharmacol; 2018 Jan; 74(1):37-44. PubMed ID: 28986606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the CYP oxidoreductase Ala503Val polymorphism on CYP3A activity in vivo: a randomized, open-label, crossover study in healthy Chinese men.
    Yang G; Fu Z; Chen X; Yuan H; Yang H; Huang Y; Ouyang D; Tan Z; Tan H; Huang Z; Zhou H
    Clin Ther; 2011 Dec; 33(12):2060-70. PubMed ID: 22177374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the Selective Orexin-1 Receptor Antagonist ACT-539313 on the Pharmacokinetics of the CYP3A Probe Drug Midazolam in Healthy Male Subjects.
    Berger B; Kaufmann P; Koch A; Dingemanse J
    J Clin Pharmacol; 2020 Jul; 60(7):931-941. PubMed ID: 32035014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probe of CYP3A by a single-point blood measurement after oral administration of midazolam in healthy elderly volunteers.
    Krupka E; Venisse N; Lafay C; Gendre D; Diquet B; Bouquet S; Perault MC
    Eur J Clin Pharmacol; 2006 Aug; 62(8):653-9. PubMed ID: 16832678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of quercetin on CYP3A activity in Chinese healthy participants.
    Duan KM; Wang SY; Ouyang W; Mao YM; Yang LJ
    J Clin Pharmacol; 2012 Jun; 52(6):940-6. PubMed ID: 21680781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Composite midazolam and 1'-OH midazolam population pharmacokinetic model for constitutive, inhibited and induced CYP3A activity.
    Wiebe ST; Meid AD; Mikus G
    J Pharmacokinet Pharmacodyn; 2020 Dec; 47(6):527-542. PubMed ID: 32772302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative prediction of hepatic CYP3A activity using endogenous markers in healthy subjects after administration of CYP3A inhibitors or inducers.
    Lee J; Yoon SH; Yi S; Kim AH; Kim B; Lee S; Yu KS; Jang IJ; Cho JY
    Drug Metab Pharmacokinet; 2019 Aug; 34(4):247-252. PubMed ID: 31088714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the relationship between expression of cytochrome P450 enzymes and gefitinib pharmacokinetics.
    Swaisland HC; Cantarini MV; Fuhr R; Holt A
    Clin Pharmacokinet; 2006; 45(6):633-44. PubMed ID: 16719544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of the CYP3A5*3 and CYP3A4*1G polymorphisms with the pharmacokinetics of oral midazolam and the urinary 6β-hydroxycortisol/cortisol ratio as markers of CYP3A activity in healthy male Chinese.
    Chan SW; Xiao Y; Hu M; Yin OQ; Chu TT; Fok BS; Lee VH; Tomlinson B
    J Clin Pharm Ther; 2016 Oct; 41(5):552-8. PubMed ID: 27511886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nanogram dose of the CYP3A probe substrate midazolam to evaluate drug interactions.
    Halama B; Hohmann N; Burhenne J; Weiss J; Mikus G; Haefeli WE
    Clin Pharmacol Ther; 2013 Jun; 93(6):564-71. PubMed ID: 23511711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amenamevir: Studies of Potential CYP3A-Mediated Pharmacokinetic Interactions With Midazolam, Cyclosporine, and Ritonavir in Healthy Volunteers.
    Adeloye T; Sahgal O; Puri A; Warrington S; Endo T; Dennison J; Johnston A
    Clin Pharmacol Drug Dev; 2018 Nov; 7(8):844-859. PubMed ID: 30044899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Drug-Drug Interaction Study to Evaluate the Effect of TAS-303 on CYP3A Activity in the Small Intestine and Liver.
    Kumagai Y; Fujita T; Maeda M; Sasaki Y; Nagaoka M; Huang J; Takenaka T; Kawai M
    J Clin Pharmacol; 2020 Jun; 60(6):702-710. PubMed ID: 32026490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic states.
    Yu KS; Cho JY; Jang IJ; Hong KS; Chung JY; Kim JR; Lim HS; Oh DS; Yi SY; Liu KH; Shin JG; Shin SG
    Clin Pharmacol Ther; 2004 Aug; 76(2):104-12. PubMed ID: 15289787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic interaction of intravenous fentanyl with ketoconazole.
    Ziesenitz VC; König SK; Mahlke NS; Skopp G; Haefeli WE; Mikus G
    J Clin Pharmacol; 2015 Jun; 55(6):708-17. PubMed ID: 25651378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of ticagrelor on the metabolism of midazolam in healthy volunteers.
    Teng R; Butler K
    Clin Ther; 2013 Jul; 35(7):1025-37. PubMed ID: 23870610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of ritonavir dose and schedule on CYP3A inhibition and venetoclax clinical pharmacokinetics.
    Freise KJ; Hu B; Salem AH
    Eur J Clin Pharmacol; 2018 Apr; 74(4):413-421. PubMed ID: 29302721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoinhibitory properties of the parent but not of the N-oxide metabolite contribute to infusion rate-dependent voriconazole pharmacokinetics.
    Hohmann N; Kreuter R; Blank A; Weiss J; Burhenne J; Haefeli WE; Mikus G
    Br J Clin Pharmacol; 2017 Sep; 83(9):1954-1965. PubMed ID: 28370390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of breviscapine and C3435T
    Zhao Y; Miao Z; Jiang M; Zhou X; Lai Y
    Xenobiotica; 2021 Mar; 51(3):366-372. PubMed ID: 33256506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between Endogenous Plasma Biomarkers of Constitutive Cytochrome P450 3A Activity and Single-Time-Point Oral Midazolam Microdose Phenotype in Healthy Subjects.
    Woolsey SJ; Beaton MD; Choi YH; Dresser GK; Gryn SE; Kim RB; Tirona RG
    Basic Clin Pharmacol Toxicol; 2016 Apr; 118(4):284-91. PubMed ID: 26399557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of CYP2C9 genetic polymorphism and breviscapine on losartan pharmacokinetics in healthy subjects.
    Huang HX; Wu H; Zhao Y; Zhou T; Ai X; Dong Y; Zhang Y; Lai Y
    Xenobiotica; 2021 May; 51(5):616-623. PubMed ID: 33509019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.